Sign Up Today and Learn More About HepaRegeniX Stock
Invest in or calculate the value of your shares in HepaRegeniX or other pre-IPO companies through EquityZen's platform.
HepaRegeniX Stock (HEPX)
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
About HepaRegeniX Stock
Founded
2015
Industries
Science and Engineering, Health Care, Biotechnology
HepaRegeniX Press Mentions
Stay in the know about the latest news on HepaRegeniX
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
globenewswire • May 08, 2025
HepaRegeniX lands €21.5m to advance liver regeneration drug
longevity • Apr 18, 2025
HepaRegeniX Closes €21.5M in Funding
finsmes • Apr 16, 2025
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
biospace • Apr 15, 2025
HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration
einpresswire • Apr 15, 2025
HepaRegeniX Management
Leadership team at HepaRegeniX
Chief Scientific Officer
Birgit Jung
CEO
Michael Lutz
Join now and verify your accreditation status to gain access to:
- HepaRegeniX Current Valuation
- HepaRegeniX Stock Price
- HepaRegeniX Management
- Available deals in HepaRegeniX and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- HepaRegeniX Cap Table and Funding History by Share Class and Liquidity Preferences
- HepaRegeniX Revenue and Financials
- HepaRegeniX Highlights
- HepaRegeniX Business Model
- HepaRegeniX Risk Factors
- HepaRegeniX Research Report from SACRA Research
Trading HepaRegeniX Stock
How to invest in HepaRegeniX stock?
Accredited investors can buy pre-IPO stock in companies like HepaRegeniX through EquityZen funds. These investments are made available by existing HepaRegeniX shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HepaRegeniX stock?
Shareholders can sell their HepaRegeniX stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
